BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 76.20
-0.10 (-0.13%)
Jun 3, 2026, 5:29 PM CET
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €19.27 billion as of June 3, 2026. Its market cap has decreased by -3.70% in one year.
Market Cap
19.27B
Enterprise Value
5.96B
Revenue
2.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
€76.20
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 19.27B, an increase of 608.28%. That is a compound annual growth rate of 34.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 19.36B | -0.70% |
| Dec 31, 2025 | 19.50B | -26.11% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 56.89B |
| Siemens Healthineers AG | 38.96B |
| Bayer Aktiengesellschaft | 35.89B |
| Fresenius SE & Co. KGaA | 20.43B |
| Sartorius Aktiengesellschaft | 15.19B |
| Fresenius Medical Care AG | 9.99B |
| Fielmann Group AG | 3.75B |
| Ottobock SE & Co. KGaA | 3.38B |